Encompass Health Return on Tangible Equity 2010-2025 | EHC

Current and historical return on tangible equity values for Encompass Health (EHC) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Encompass Health Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-06-30 $0.52B $1.43B 41.53%
2025-03-31 $0.50B $1.30B 44.03%
2024-12-31 $0.46B $1.21B 45.57%
2024-09-30 $0.42B $1.09B 48.51%
2024-06-30 $0.40B $0.89B 53.53%
2024-03-31 $0.38B $0.81B 58.81%
2023-12-31 $0.35B $0.70B 66.32%
2023-09-30 $0.35B $0.59B 82.67%
2023-06-30 $0.31B $0.47B 96.60%
2023-03-31 $0.27B $0.37B 229.18%
2022-12-31 $0.27B $0.28B -345.22%
2022-09-30 $0.27B $0.18B 298.64%
2022-06-30 $0.33B $-0.35B -335.71%
2022-03-31 $0.39B $-0.42B -221.41%
2021-12-31 $0.41B $0.96B -167.14%
2021-09-30 $0.41B $-0.58B -59.53%
2021-06-30 $0.38B $-0.67B -51.00%
2021-03-31 $0.31B $-0.70B -37.16%
2020-12-31 $0.29B $-0.78B -31.95%
2020-09-30 $0.27B $-0.87B -27.55%
2020-06-30 $0.29B $-0.94B -27.69%
2020-03-31 $0.34B $-0.98B -32.98%
2019-12-31 $0.36B $-1.09B -34.83%
2019-09-30 $0.32B $-1.12B -31.72%
2019-06-30 $0.31B $-0.97B -32.38%
2019-03-31 $0.31B $-0.93B -32.09%
2018-12-31 $0.29B $-0.99B -30.26%
2018-09-30 $0.34B $-0.94B -35.18%
2018-06-30 $0.32B $-1.02B -32.27%
2018-03-31 $0.29B $-0.93B -29.22%
2017-12-31 $0.27B $-0.98B -24.79%
2017-09-30 $0.26B $-1.00B -21.74%
2017-06-30 $0.26B $-1.03B -19.73%
2017-03-31 $0.26B $-1.36B -18.21%
2016-12-31 $0.25B $-1.41B -17.19%
2016-09-30 $0.23B $-1.41B -15.62%
2016-06-30 $0.22B $-1.47B -17.11%
2016-03-31 $0.20B $-1.48B -18.46%
2015-12-31 $0.18B $-1.53B -20.31%
2015-09-30 $0.18B $-0.64B -24.91%
2015-06-30 $0.17B $-0.66B -31.85%
2015-03-31 $0.21B $-0.76B -54.37%
2014-12-31 $0.22B $-0.77B -99.31%
2014-09-30 $0.15B $0.00B -332.96%
2014-06-30 $0.15B $-0.04B -216.25%
2014-03-31 $0.23B $-0.06B -233.50%
2013-12-31 $0.23B $-0.08B -145.97%
2013-09-30 $0.30B $-0.10B -180.72%
2013-06-30 $0.29B $-0.15B -160.89%
2013-03-31 $0.17B $-0.30B -88.71%
2012-12-31 $0.16B $-0.11B -90.65%
2012-09-30 $0.16B $-0.16B -73.89%
2012-06-30 $0.17B $-0.20B -66.60%
2012-03-31 $0.15B $-0.25B -48.80%
2011-12-31 $0.18B $-0.28B -53.71%
2011-09-30 $0.91B $-0.31B -232.95%
2011-06-30 $0.89B $-0.37B -141.14%
2011-03-31 $0.91B $-0.41B -106.70%
2010-12-31 $0.87B $-0.48B -80.68%
2010-09-30 $0.13B $-1.26B -10.14%
2010-06-30 $0.12B $-1.28B -8.79%
2010-03-31 $0.06B $-1.31B -4.61%
2009-12-31 $0.07B $-1.36B -4.74%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.264B $5.373B
Encompass Health Corporation is a provider of integrated healthcare services. It offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The company delivers high-quality, cost-effective, integrated care in the healthcare space. It provides a continuum of facility-based and home-based post-acute services for its patients and their families, which will gain more prevalence as coordinated care and integrated delivery payment models, such as accountable care organizations and bundled payment arrangements. The company operates through two segments: Inpatient Rehabilitation as well as Home Health and Hospice business.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $20.312B 19.41
DaVita (DVA) United States $9.850B 14.09
Elanco Animal Health (ELAN) United States $9.117B 20.39
Chemed (CHE) United States $6.673B 22.35
RadNet (RDNT) United States $5.520B 199.33
Option Care Health (OPCH) United States $4.655B 19.92
LifeStance Health (LFST) United States $2.131B 0.00
Addus HomeCare (ADUS) United States $2.123B 22.85
Astrana Health (ASTH) United States $1.792B 62.67
Aveanna Healthcare Holdings (AVAH) United States $1.671B 30.77
U.S Physical Therapy (USPH) United States $1.260B 31.52
Atai Life Sciences (ATAI) Germany $0.982B 0.00
Pennant (PNTG) United States $0.830B 29.28
Daxor (DXR) United States $0.053B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.051B 0.00
Psychemedics (PMD) United States $0.000B 0.00